NCT00317512 - Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

April 30, 2005

Study Completion Date

July 31, 2007

Conditions

Angina PectorisUnstable AnginaMyocardial Infarction

Interventions

PROCEDURE

Percutaneous Coronary Revascularization

DRUG

Hemoglobin-Based Oxygen Carrier-201 (HBOC-201)

DRUG

Voluven

Trial Locations (6)

Site # 5 Onze Lieve Vrouw Ziekenhuis (OLVZ), Aalst

Site # 6 Antwerpen, Antwerp

Site # 2 Herzzentrum, Leipzig

Site # 3 OLVG Amsterdam, Amsterdam

Site # 4 Academisch Medisch Centrum (AMC), Amsterdam

Site # 1 Erasmus Medical Center, Rotterdam